Using the univariate model and comparing the two MS patient subgroups, we found that patients with CSF adiponectin levels above the arbitrary cut-off had significantly higher BMI, serum adiponectin, MSSS and EDSS at the end of the 4.5-year follow-up (see Table 3). Here, ADIPOQ is linked to myeloid sarcoma.